Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE

NCT05644210 · clinicaltrials.gov ↗

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Antiphospholipid Syndrome

Interventions

DRUG: Telitacicept
DRUG: Rituximab
DRUG: Aspirin
DRUG: Warfarin
DRUG: Hydroxychloroquine
DRUG: Prednisone

Sponsor

Qilu Hospital of Shandong University